NS-136
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NS-136, covering 2024-11-19 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Study to Evaluate the Efficacy and Safety of NS-136 in the Treatment of Schizophrenia [Phase 2]